Skip to content

Diana Dias Da Silva

11 papers in the library · 257 citations · publishing 2018-2026

Papers

Sort Most recent Most cited

Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han rats

Science Letters April 17, 2026 Francisco Sacadura, Cláudia Marques, Andreia Machado Brito-Da-Costa et al.

Background: Psilocybin, the main psychoactive compound found in Psilocybe mushrooms, has gained increasing attention due to its potential therapeutic effects in neuropsychiatric disorders [1]. Beyond its central effects, increasing evidence highlights the relevance of the gut–brain axis, suggesting that psychedelics may also influence intestinal microbiota composition. Whole mushroom extracts...

Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in rats

Science Letters April 17, 2026 Diana Dias Da Silva, Andreia Machado Brito-Da-Costa, Francisco Sacadura et al.

Background: Psilocybin, a key psychoactive compound found in Psilocybe mushrooms, has gained increasing attention due to its therapeutic potential in neuropsychiatric disorders [1]. However, comparative preclinical data between isolated psilocybin and whole mushroom extracts remain scarce, particularly regarding behavioural reinforcement and peripheral toxicity [2,3]. Objective: To compare the...

In vitro neuronal characterization of the entheogenic plant Tagetes lucida Cav.

Science Letters April 11, 2026 Maria Eduarda Bertino Nahim Garcia, Ema Santos, Diana Dias Da Silva et al.

Background: Holding a relevant ritualistic and ethnomedicinal value among the Mesoamerican tribes, Tagetes lucida Cav. has recently seen its uses being translated into Western communities, primarily for recreational ends, given its psychoactivity. Despite the new popularity resurgence of entheogens, the available data concerning this plant’s pharmacological and safety profile remain scarce...

Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making

Instituto Politécnico do Porto February 27, 2026 C Faria, Diana Dias Da Silva, João José Sousa

Background: Major depressive disorder (MDD) is a highly prevalent and disabling psychiatric condition associated with substantial clinical, social, and economic burden [1,2]. Despite the availability of conventional antidepressants, their limited effectiveness, delayed onset of action, and high relapse rates have renewed interest in innovative therapeutic approaches [3,4,5]. Psilocybin-assisted...

Rare but relevant: MDMA and hyponatraemia

Addiction December 8, 2025 María Rita Concepción García, Nelson G. M. Gomes, Diana Dias Da Silva

Conventionally used for its stimulant, empathogenic and entactogenic effects, 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is one of the most commonly used psychoactive drugs, specifically among young adults and in nightlife and recreational party contexts. Often perceived as a safe drug, MDMA can display an array of toxic effects on multiple organs, with hyponatraemia (a low blood sodium...

Mexican calea (Calea zacatechichi Schltdl.) interferes with cholinergic and dopaminergic pathways and causes neuroglial toxicity.

Journal of Ethnopharmacology January 30, 2025 Maria Rita Garcia, Federico Ferreres, Tiago Mineiro et al. 3 citations

The use of "Mexican calea" (Calea zacatechichi Schltdl.) in ritualistic ceremonies, due to its dream-inducing effects, was until recently limited to indigenous communities in Mexico. However, the plant has recently gained popularity in Western societies being commonly used in recreational settings. Despite the traditional and recreational uses, mechanisms underlying its reported oneirogenic...

Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell Model

RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia 2025 Andreia Machado Brito-Da-Costa, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho et al.

Psychedelic compounds, including psilocybin, psilocin, lysergic acid diethylamide (LSD), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), and mescaline, have long been recognized for their recreational effects and involvement in forensic cases. They have recently gained attention also for their potential therapeutic applications in treating neurological and psychiatric disorders [1]. Despite this...

Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.

Pharmaceuticals (Basel, Switzerland) February 25, 2021 Carolina Lobato-Freitas, Andreia Machado Brito-Da-Costa, Ricardo Jorge Dinis-Oliveira et al.

ADB-FUBINACA and AMB-FUBINACA are two synthetic indazole-derived cannabinoid receptor agonists, up to 140- and 85-fold more potent, respectively, than trans-∆9-tetrahydrocannabinol (∆9-THC), the main psychoactive compound of cannabis. Synthesised in 2009 as a pharmaceutical drug candidate, the recreational use of ADB-FUBINACA was first reported in 2013 in Japan, with fatal cases being described...

Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects

Pharmaceuticals February 3, 2021 Andreia Machado Brito-Da-Costa, Áurea Madureira-Carvalho, Diana Dias Da Silva et al. 42 citations

Salvia divinorum Epling and Játiva is a perennial mint from the Lamiaceae family, endemic to Mexico, predominantly from the state of Oaxaca. Due to its psychoactive properties, S. divinorum had been used for centuries by Mazatecans for divinatory, religious, and medicinal purposes. In recent years, its use for recreational purposes, especially among adolescents and young adults, has...

Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact.

Pharmaceuticals (Basel) October 23, 2020 Andreia Machado Brito-Da-Costa, Diana Dias Da Silva, Nelson G. M. Gomes et al. 111 citations

Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact.

Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions

Current Molecular Pharmacology October 15, 2018 Ricardo Jorge Dinis-Oliveira, Carolina Lança Pereira, Diana Dias Da Silva 101 citations

Background:Mescaline (3,4,5-trimethoxyphenethylamine), mainly found in the Peyote cactus (Lophophora williamsii), is one of the oldest known hallucinogenic agents that influence human and animal behavior, but its psychoactive mechanisms remain poorly understood.Objective:This article aims to fully review pharmacokinetics and pharmacodynamics of mescaline, focusing on the in vivo and in vitro...